Ann: Complete Regression of TNBC Tumours and Protective Immunity, page-96

First 96 Last

Share
Profile

Follow
Taipan88888

2,308 Posts.

225

28/10/21

17:21

Post #: 57153827
Share

Originally posted by Steini: ↑

Agree totally with you but we can't blame the majority of traders today who give a damn about it, their business is the profitable in and out of a stock regardless of what it does.

I am excited by the immune system response and its re-attacking the re-introduced cancer without stimulus. Exactly the same success as IMU's CF33 OV - the holy grail.

That has to be digested but those who never did any research on this topic aren't able to understand the significance. Killing the cancer from the outside for a period of time is one thing, keeping it down for ever is another. That's what attracts big pharma's money.

Despite the above, patience is required.

The sp could have another leap to, imo, fair value at 5-6c or get smashed by profit takers, anything is possible.

Value estimation: similar techs were bought out recently for at least USD 500m / AUD 670m. Just applying AUD 300m, max 6b shares = 5c

GLTA

Expand

Yes Steini well said..

Traders will be traders etc etc and bounce the price around short term.
I think we all have done some of that type of trading We all have bills to pay.

Patience is required with this type of stock in it's early days..
BUT.... WOW what a great announcement!!!

Goodluck to all..

IVX Price at posting: 3.1¢ Sentiment: Buy Disclosure: Held
4 Upvote

0 Great analysis

Reply

Top Stories

VBX Ltd jumps 15% on ASX debut as newest Oz bauxite player

ASX Market Close: Bourse spins in circles as Israel-Iran conflict weighs | June 17, 2025

MEM

Many are concerned about global falling birthrates. This diverse stock has solutions

RCE

Recce locks in $30M to boost commercialisation across ASEAN region

Listen: HotCopper Wire Podcast 013 - They changed the IPO rules (and that's a good thing)

First 96 Last

Add to My Watchlist

What is My Watchlist?

A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

(20min delay)
Last 13.5¢		Change 0.000(0.00%)		Mkt cap ! $11.43M

Open	High	Low	Value	Volume
12.5¢	13.5¢	12.5¢	$3.286K	26.26K

Buyers (Bids)

No.	Vol.	Price($)
1	24920	12.5¢

Sellers (Offers)

Price($)	Vol.	No.
13.5¢	9938	1

View Market Depth

No.	Vol.	Price($)
1	24920	0.125
3	209200	0.120
2	227489	0.115
2	15520	0.105
5	65300	0.100

Price($)	Vol.	No.
0.135	9938	1
0.140	25770	2
0.145	92607	3
0.150	146065	4
0.155	110008	2

Last trade - 15.31pm 17/06/2025 (20 minute delay)

IVX (ASX) Chart

Ann: Complete Regression of TNBC Tumours and Protective Immunity, page-96

VBX Ltd jumps 15% on ASX debut as newest Oz bauxite player

ASX Market Close: Bourse spins in circles as Israel-Iran conflict weighs | June 17, 2025

Many are concerned about global falling birthrates. This diverse stock has solutions

Recce locks in $30M to boost commercialisation across ASEAN region

Listen: HotCopper Wire Podcast 013 - They changed the IPO rules (and that's a good thing)

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

Ann: Complete Regression of TNBC Tumours and Protective Immunity, page-96

Top Stories

VBX Ltd jumps 15% on ASX debut as newest Oz bauxite player

ASX Market Close: Bourse spins in circles as Israel-Iran conflict weighs | June 17, 2025

Many are concerned about global falling birthrates. This diverse stock has solutions

Recce locks in $30M to boost commercialisation across ASEAN region

Listen: HotCopper Wire Podcast 013 - They changed the IPO rules (and that's a good thing)

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News